Related references
Note: Only part of the references are listed.Discovery of [11C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors
Christopher D. Cox et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents
Renee C. Gentzel et al.
NEUROPHARMACOLOGY (2015)
In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents
Kazunori Suzuki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
AMG 580: A Novel Small Molecule Phosphodiesterase 10A (PDE10A) Positron Emission Tomography Tracer
Hang Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
In Vivo Assessment and Dosimetry of 2 Novel PDE10A PET Radiotracers in Humans: 18F-MNI-659 and 18F-MNI-654
Olivier Barret et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human
Christophe Plisson et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates
Dah-Ren Hwang et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Quantification of 18F-JNJ-42259152, a Novel Phosphodiesterase 10A PET Tracer: Kinetic Modeling and Test-Retest Study in Human Brain
Koen Van Laere et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Preclinical evaluation of [18F]JNJ42259152 as a PET tracer for PDE10A
S. Celen et al.
NEUROIMAGE (2013)
The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey
Sean M. Smith et al.
NEUROPHARMACOLOGY (2013)
Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia
Izzat T. Raheem et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
Paul Morgan et al.
DRUG DISCOVERY TODAY (2012)
Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain
Zhude Tu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Radiosynthesis and in vivo evaluation of [11C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A
Christophe Plisson et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies
Emma Perez-Costas et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Biochemical and Behavioral Profiles of Phosphodiesterase Inhibition in Dopaminergic Neurotransmission
Akinori Nishi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
Viktor Lakics et al.
NEUROPHARMACOLOGY (2010)
Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
Sarah Threlfell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
Steven M. Grauer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Inverse Agonist Histamine H3 Receptor PET Tracers Labelled With Carbon-11 or Fluorine-18
Terence G. Hamill et al.
SYNAPSE (2009)
Preclinical characterization of selective phosphodiesterase 10A inhibitors: A new therapeutic approach to the treatment of schizophrenia
C. J. Schmidt et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
In vivo site-directed radiotracers: a mini-review
Shil Patel et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species
Timothy M. Coskran et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats
JS Rodefer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Share Paper
